v3.22.2.2
Commitments and Contingencies (Details Narrative) - USD ($)
1 Months Ended 3 Months Ended 5 Months Ended 6 Months Ended 12 Months Ended
Oct. 31, 2019
Jan. 31, 2019
Jun. 30, 2022
Jun. 30, 2021
Nov. 21, 2022
Jun. 30, 2022
Jun. 30, 2021
Dec. 31, 2021
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                
Research and development expenses     $ 555,010 $ 355,051   $ 1,019,515 $ 590,815  
Accrued research and development expenses     1,500,937     1,500,937   $ 1,097,021
Litigation Settlement, Amount Awarded from Other Party $ 267,680              
Loss Contingency, Damages Sought, Value               103,088
Reapayment for notes     146,912          
Promissory Notes [Member]                
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                
Debt Instrument, Face Amount   $ 250,000            
Debt Instrument, Maturity Date   Mar. 16, 2016            
Yeda Research and License Agreement [Member]                
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                
Research and development expenses     15,000 13,000   29,000 48,000  
Accrued research and development expenses     0     0   0
MD Anderson Sponsored Research Agreements [Member]                
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                
Research and development expenses     429,505 $ 313,384   964,515 $ 514,148  
Accrued research and development expenses     $ 527,524     $ 527,524   $ 411,773
MD Anderson Sponsored Research Agreements [Member] | Subsequent Event [Member]                
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                
Research and development expenses         $ 1,300,000